Population | 0.15% cyfluthrin | 0.05% α-cypermethrin | 0.05% deltamethrin | 1% fenitrothion | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | KT50/min (95% CI) | Mort (%) (mean ± SD) | Status | n | KT50/min (95% CI) | Mort (%) (mean ± SD) | Status | n | KT50/min (95% CI) | Mort (%) (mean ± SD) | Status | n | KT50/min (95% CI) | Mort (%) (mean ± SD) | Status | |
Laboratory susceptible strain | 120 | 10.61 (9.22–11.76) | 100.00 ± 0.00 | S | 123 | 21.18 (19.60–22.86) | 99.02 ± 0.58 | S | 121 | 17.19 (16.09–18.32) | 100.00 ± 0.00 | S | 132 | 55.05 (50.73–61.15) | 98.61 ±  1.76 | S |
CM-Dongtan population | 105 | 16.69 (15.15–18.22) | 91.90 ± 7.33 | PR | 144 | 20.46 (19.10–21.93) | 81.19 ± 12.19 | PR | 120 | 24.71 (22.34–27.20) | 98.03 ± 3.40 | S | 123 | 109.50 (76.71–558.23) | 100.00 ± 0.00 | S |
CM-Xinhe population | 174 | 64.72 (52.22–98.61) | 64.76 ± 6.17** | R | 150 | 77.29 (60.87–114.90) | 21.23 ± 7.02** | R | 108 | 89.56 (65.77–162.03) | 26.57 ± 20.01** | R | 108 | 130.14 (86.65–506.19) | 51.77 ± 16.11* | R |